The Cigna Groupvs.McKesson
CI vs MCK · both in Distribution & pharmacy infrastructure, part of the Medicine, pharma & life science value chain: Wholesalers, distribution and pharmacy chains that get medicines to patients.
McKesson is about 1.2× larger than The Cigna Group by market cap; The Cigna Group trades at the lower P/E (12.3 vs 19.8); year to date, The Cigna Group leads (+6.6% vs −1.7%).
Side by side
| CI | MCK | |
|---|---|---|
| Market cap | $77.6B | $94.4B |
| Price | $293.46 | $805.96 |
| Today | +0.6% | +1.7% |
| Return YTD | +6.6% | −1.7% |
| Return 1Y | −5.0% | +12.8% |
| P/E | 12.3 | 19.8 |
| P/S | 0.3 | 0.2 |
| P/B | 1.8 | 16.0 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
The Cigna GroupCI
Health services group with pharmacy benefit management (Express Scripts) and health insurance.
Full CI profile →McKessonMCK
American pharmaceutical wholesaler — one of the largest distributors of medicines to pharmacies, hospitals and clinics in the US.
Full MCK profile →More comparisons in Distribution & pharmacy infrastructure
See where CI and MCK sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →